Divi’s LaboratoriesLeadership
Divi’s LaboratoriesDivi’s Laboratories DIVISLAB · NSE, BSE

Divi’s Laboratories Leadership: founders, CEO and board

Reviewed by the editorial team · Updated 5 Nov 2026 · Last verified 5 Nov 2026 · 1 min read
Quick answer

Divi's is run by MD Murali Divi and CEO Kiran S. Divi 14. Venkatesa Perumallu Pasumarthy became CFO in August 2025 153.

Founded1990, Hyderabad (as Divi's Research Centre)
StatusListed
Listed onNSE, BSE: DIVISLAB

Top team

Name Role
Murali Divi Managing director 14
Kiran S. Divi Whole-time director and CEO 14
Nilima Prasad Divi Whole-time director (commercial) 3
N.V. Ramana Executive director 14
Venkatesa Perumallu Pasumarthy Chief financial officer, from 1 August 2025 153
M. Satish Choudhury Company secretary and chief investor relations officer 3

Changes

L. Kishore Babu retired as CFO on 1 August 2025 and was succeeded by Venkatesa Perumallu Pasumarthy, previously general manager for finance 15. Kiran Divi and N.V. Ramana came up for reappointment by rotation at the August 2026 AGM 14.

Board

Other directors include Ramesh B.V. Nimmagadda, Ganapaty Seru, Sunaina Singh, K.V. Chowdary, S. Devendra Rao and Rajendra Kumar Premchand 16. MarketScreener lists both Murali Divi and Ramesh Nimmagadda as chairman, so we could not confirm who holds the title 16.

Family

Kiran Divi is Murali Divi's son and Nilima Prasad Divi his daughter 3. Both are among the largest shareholders 8.

Frequently asked questions

Kiran S. Divi, son of founder Murali Divi.
Venkatesa Perumallu Pasumarthy, since August 2025.
Sources✓ Verified 5 Nov 2026
1 Forbes, Murali Divi & family (Real-Time Billionaires), 5 Nov 2026, Murali Divi 2 Divi's Laboratories, Annual Report 2025-26, 11 Jul 2026, annual report 3 Divi's Laboratories, Q4 FY26 earnings conference call transcript, 23 May 2026, Q4 FY26 call 4 Venture Intelligence, Who is Murali Divi?, 20 Jan 2009, founding, quoting Businessworld 5 Bloomberg, Murali Divi, Bloomberg Billionaires Index, 6 Nov 2026, listing 6 Groww, Divi's Laboratories Q4 FY26 results, 25 May 2026, FY26 results 7 Divi's Laboratories, Outcome of 35th AGM, 11 Aug 2025, FY25 exports 8 Trendlyne, Divi's Laboratories shareholding, 30 Sep 2026, shareholding 9 ScanX, Divi's Laboratories promoter group declares no encumbrance in FY26, 1 Jan 1970, no encumbrance 10 Wikipedia, Divi's Laboratories, 6 Nov 2026, history 11 5paisa, Meet the billionaire behind Divi's Laboratories, 9 Dec 2022, Murali Divi career 12 Business Standard, Divi's Laboratories: valuations may limit stock gains, 11 Nov 2025, Kakinada, custom synthesis 13 Business Standard, USFDA lifts import alert on Divi's Vizag plant, 2 Nov 2017, FDA import alert 14 Divi's Laboratories, 36th AGM Notice, 23 May 2026, board roles 15 MarketScreener, Divi's Laboratories announces executive changes effective 1 August 2025, 17 May 2025, CFO change 16 MarketScreener, Divi's Laboratories company profile, 6 Nov 2026, directors 17 Divi's Laboratories, API manufacturer, 6 Nov 2026, products 18 Legacis Capital, Indian CDMO FY26 winners vs narrative, 29 Jun 2026, peer revenue 19 Whalesbook, Piramal Pharma posts ₹326 crore loss in FY26, 28 Apr 2026, Piramal Pharma 20 Whalesbook, Divi's Labs FY26 profit, invests ₹1,500 crore, 15 Jul 2026, capex, peptide centre 21 Screener, Divi's Laboratories consolidated, 5 Nov 2026, financials, market value 22 Kotak Neo, Divi's Labs Q4 results: PAT rises 13% to Rs 751 crore, 25 May 2026, Q4 FY26 23 Indian Pharma Post, Divi's Laboratories Q1 FY27 PAT jumps 66% to Rs 902 crore, 3 Aug 2026, Q1 FY27 24 Deccan Chronicle, Visakhapatnam villagers oppose Divi's expansion, 23 Feb 2016, Chippada protest 25 The News Minute, AP asks Divi's Lab not to go ahead with facility after clash with locals, 20 Dec 2020, Kakinada protest 26 Trendlyne, Divi's Laboratories latest news and filings, 6 Nov 2026, filings Report a correction

This page is for information only and is not investment advice.